Harmony Biosciences Holdings Inc [NASDAQ: HRMY] slipped around -1.67 points on Thursday, while shares priced at $32.13 at the close of the session, down -4.94%.
Compared to the average trading volume of 508.25K shares, HRMY reached a trading volume of 4994877 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Harmony Biosciences Holdings Inc [HRMY]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HRMY shares is $47.11 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HRMY stock is a recommendation set at 1.89. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Harmony Biosciences Holdings Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 10, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Buy. The new note on the price target was released on September 10, 2024, representing the official price target for Harmony Biosciences Holdings Inc stock. Previously, the target price had yet another raise to $48, while Citigroup analysts kept a Buy rating on HRMY stock.
The Average True Range (ATR) for Harmony Biosciences Holdings Inc is set at 2.03, with the Price to Sales ratio for HRMY stock in the period of the last 12 months amounting to 2.69. The Price to Book ratio for the last quarter was 3.07, with the Price to Cash per share for the same quarter was set at 7.20. Price to Free Cash Flow for HRMY in the course of the last twelve months was 8.32 with Quick ratio for the last quarter at 3.20.
How has HRMY stock performed recently?
Harmony Biosciences Holdings Inc [HRMY] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.64. With this latest performance, HRMY shares dropped by -9.67% in over the last four-week period, additionally plugging by 1.39% over the last 6 months – not to mention a rise of 36.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HRMY stock in for the last two-week period is set at 41.11, with the RSI for the last a single of trading hit 39.41, and the three-weeks RSI is set at 42.64 for Harmony Biosciences Holdings Inc [HRMY]. The present Moving Average for the last 50 days of trading for this stock 36.36, while it was recorded at 35.53 for the last single week of trading, and 32.79 for the last 200 days.
Harmony Biosciences Holdings Inc [HRMY]: Deeper insight into the fundamentals
Harmony Biosciences Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.20 and a Current Ratio set at 3.24.
Earnings analysis for Harmony Biosciences Holdings Inc [HRMY]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HRMY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Harmony Biosciences Holdings Inc go to 22.82%.
Insider trade positions for Harmony Biosciences Holdings Inc [HRMY]
There are presently around $93.28%, or 116.14%% of HRMY stock, in the hands of institutional investors. The top three institutional holders of HRMY stocks are: VALOR MANAGEMENT LLC with ownership of 11.22 million shares, which is approximately 19.7601%. BLACKROCK INC., holding 5.84 million shares of the stock with an approximate value of $$176.05 million in HRMY stocks shares; and BLACKROCK INC., currently with $$158.03 million in HRMY stock with ownership which is approximately 9.2263%.
